HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Personal Folders Download to citation manager Author home page(s): Jochen Cremer Permission Requests Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Cremer, J. Search for Related Content PubMed PubMed Citation Articles by Cremer, J. Related Collections Cardiac - other Coronary disease

Eur J Cardiothorac Surg 2007;32:559. doi:10.1016/j.ejcts.2007.01.053
Copyright © 2007, European Association for Cardio-Thoracic Surgery. Published by Elsevier B.V. All rights reserved

Editorial

Fibrin glue in coronary surgery

University Hospital Schleswig-Holstein, Campus Kiel, Germany

^_* Corresponding author. (Email: jcremer@kielheart.uni-kiel.de).

The first 20% of the full text of this article appears below.

Adjunctive application of fibrin sealant in coronary artery bypass graft (CABG) surgery has been established over years for various indications, such as bleeding from distal or proximal anastomoses, fixation of the bypass course, diffuse epicardial bleeding, sealing of the IMA-bed, and intrasternal application for profound bone marrow bleeding. Moreover, fibrin sealant has been used in surgical fields with diffuse bleeding, e.g. in cardiac re-operations, for pre-clotting of Dacron prostheses, in thoracic organ transplantation, aortic aneurysm surgery, and in complex congenital heart surgery.

The publications of Görler et al. [1] and Lamm et al. [2] from distinguished heart centers are presenting data showing an unfavorable risk–benefit relation based on safety issues after the application of Tissucol^® Duo S in CABG surgery. Both papers assess a . . . [Full Text of this Article]